Cargando…

Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma

BACKGROUND: The benefits of new innovations in glioblastoma therapies should not be curtailed as a result of delays in commencement of radiation therapy, caused by clinical circumstances as well as diagnostic procedures. This study evaluates whether delays in chemo-radiotherapy after surgery, while...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adeberg, Sebastian, Bostel, Tilman, Harrabi, Semi, Bernhardt, Denise, Welzel, Thomas, Wick, Wolfgang, Debus, Juergen, Combs, Stephanie E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518587/ https://www.ncbi.nlm.nih.gov/pubmed/26223282 http://dx.doi.org/10.1186/s12885-015-1545-x

Ejemplares similares

A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?
por: Adeberg, Sebastian, et al.
Publicado: (2014)

Do Increased Doses to Stem-Cell Niches during Radiation Therapy Improve Glioblastoma Survival?
por: Adeberg, Sebastian, et al.
Publicado: (2016)

Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects
por: Harrabi, Semi B, et al.
Publicado: (2014)

Dosimetric Comparison of Proton Radiation Therapy, Volumetric Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy Based on Intracranial Tumor Location
por: Adeberg, Sebastian, et al.
Publicado: (2018)

Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?
por: Combs, Stephanie E, et al.
Publicado: (2011)

Treatment of meningioma and glioma with protons and carbon ions
por: Adeberg, Sebastian, et al.
Publicado: (2017)

Metformin Enhanced in Vitro Radiosensitivity Associates with G2/M Cell Cycle Arrest and Elevated Adenosine-5’-monophosphate-activated Protein Kinase Levels in Glioblastoma
por: Adeberg, Sebastian, et al.
Publicado: (2017)

DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma
por: Adeberg, Sebastian, et al.
Publicado: (2022)

Dose-Limiting Organs at Risk in Carbon Ion Re-Irradiation of Head and Neck Malignancies: An Individual Risk-Benefit Tradeoff
por: Held, Thomas, et al.
Publicado: (2019)

Neurocognitive Outcomes in Pediatric Patients Following Brain Irradiation
por: Weusthof, Katharina, et al.
Publicado: (2021)

Clinical Management of Blood–Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer
por: Held, Thomas, et al.
Publicado: (2019)

S-phase–specific radiosensitization by gemcitabine for therapeutic carbon ion exposure in vitro
por: Harrabi, Semi B., et al.
Publicado: (2016)

Adenoid cystic Carcinoma and Carbon ion Only irradiation (ACCO): Study protocol for a prospective, open, randomized, two-armed, phase II study
por: Lang, Kristin, et al.
Publicado: (2021)

The Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma Multiforme
por: Kirstein, Anna, et al.
Publicado: (2020)

Prior surgical intervention and tumor size impact clinical outcome after precision radiotherapy for the treatment of optic nerve sheath meningiomas (ONSM)
por: Adeberg, Sebastian, et al.
Publicado: (2011)

Spinal bone metastases in gynecologic malignancies: a retrospective analysis of stability, prognostic factors and survival
por: Foerster, Robert, et al.
Publicado: (2014)

EPEN-15. Radiotherapy with helium ions has the potential to improve both endocrine and neurocognitive outcome in pediatric patients with ependymoma
por: Wickert, Ricarda, et al.
Publicado: (2022)

Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma
por: Harrabi, S. B., et al.
Publicado: (2016)

Survival and recurrence patterns of multifocal glioblastoma after radiation therapy
por: Syed, Mustafa, et al.
Publicado: (2018)

Lomeguatrib Increases the Radiosensitivity of MGMT Unmethylated Human Glioblastoma Multiforme Cell Lines
por: Kirstein, Anna, et al.
Publicado: (2021)

Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist’s point of view
por: Foerster, Robert, et al.
Publicado: (2015)

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
por: Habermehl, Daniel, et al.
Publicado: (2012)

Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection
por: Habermehl, Daniel, et al.
Publicado: (2013)

Radiotherapy with Helium Ions Has the Potential to Improve Both Endocrine and Neurocognitive Outcome in Pediatric Patients with Ependymoma
por: Wickert, Ricarda, et al.
Publicado: (2022)

Improved Pathologic response to chemoradiation in MGMT methylated locally advanced rectal cancer
por: Jensen, Garrett L., et al.
Publicado: (2023)

Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023)

Resistance training concomitant to radiotherapy of spinal bone metastases – survival and prognostic factors of a randomized trial
por: Rief, Harald, et al.
Publicado: (2016)

The Patient’s Perspective on Proton Radiotherapy of Skull Base Meningioma: A Retrospective Cross-Sectional Survey
por: Seidensaal, Katharina, et al.
Publicado: (2022)

A ”Clickable” Probe for Active MGMT in Glioblastoma Demonstrates Two Discrete Populations of MGMT
por: Raghavan, Sudhir, et al.
Publicado: (2020)

Prognostic Value of Three Different Methods of MGMT Promoter Methylation Analysis in a Prospective Trial on Newly Diagnosed Glioblastoma
por: Christians, Arne, et al.
Publicado: (2012)

Acute Toxicity and Early Oncological Outcomes After Intraoperative Electron Radiotherapy (IOERT) as Boost Followed by Whole Breast Irradiation in 157 Early Stage Breast Cancer Patients—First Clinical Results From a Single Center
por: König, Laila, et al.
Publicado: (2019)

MGMT promoter methylation in Peruvian patients with glioblastoma
por: Belmar-Lopez, Carolina, et al.
Publicado: (2018)

Ways to unravel the clinical potential of carbon ions for head and neck cancer reirradiation: dosimetric comparison and local failure pattern analysis as part of the prospective randomized CARE trial
por: Held, Thomas, et al.
Publicado: (2022)

Prognostic factors for survival of women with unstable spinal bone metastases from breast cancer
por: Foerster, Robert, et al.
Publicado: (2015)

Large German Multicenter Experience on the Treatment Outcome of 207 Patients With Adenoid Cystic Carcinoma of the Major Salivary Glands
por: Akbaba, Sati, et al.
Publicado: (2020)

Particle Therapy in Adult Patients with Pelvic Ewing Sarcoma—Tumor and Treatment Characteristics and Early Clinical Outcomes
por: Schmid, Maximilian P., et al.
Publicado: (2022)

PAM-OBG: A monoamine oxidase B specific prodrug that inhibits MGMT and generates DNA interstrand crosslinks, potentiating temozolomide and chemoradiation therapy in intracranial glioblastoma
por: Sharpe, Martyn A., et al.
Publicado: (2018)

Volumetric and MGMT parameters in glioblastoma patients: Survival analysis
por: Iliadis, Georgios, et al.
Publicado: (2012)

MGMT Methylation Status: The Advent of Stratified Therapy in Glioblastoma?
por: Hau, Peter, et al.
Publicado: (2007)

Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
por: Thomas, Reena P, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_i9ss0snq1ce7co41gcdvg6leno